The FDA has extended the age indication for the Afluria Quadrivalent vaccine from 18 years of age or older to approval for use in individuals 5 years and older.

For further information, please visit the following link:

https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM574654.pdf